11. BioRiver Boost! 2024 Network and business contacts that matter
2024 Network and business contacts that matter
2024 Network and business contacts that matter
Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) has received approval from the European Commission (EC) for its Ge-68/Ga-68 radionuclide generator GalliaPharm®. The generator was first launched in 2014 and is today approved in 17 European…
Gabriele Schiattarella researches the mechanisms of heart muscle weakness at the Max Delbrück Center and Deutsches Herzzentrum der Charité (DHZC). Now the International Society for Heart Research, a highly respected professional society, has named…
These awards recognize outstanding research and innovation in biotechnology and health, rewarding top projects in human and animal health. This year, the prize money is €40,000 for human health and €25,000 for animal health.Applications deadline:…
The Max Delbrück Center, Berlin, and the biotech company AlgenScribe from Nice have agreed to cooperate to further develop their gene-editing tools. The aim is to utilize synergies, accelerate research, and ultimately develop cell therapies for…
A new collaborative study by researchers from the Berlin Institute of Health at Charité (BIH), Queen Mary University of London, University College London, University of Cambridge and the pharmaceutical company GlaxoSmithKline (GSK) shows that…
How can social robots be effectively integrated into everyday care to improve the supervision and support of senior citizens? The results of a current study at the Brandenburg University of Technology Cottbus-Senftenberg (BTU) should shed light on…
Team from Charité succeeds again in apparently fully eliminating HIV from a patient’s body
He went down in medical history: the “Berlin Patient,” the first person in the world to be cured of HIV, following a stem cell transplant at Charité –…
Deep metagenomic sequencing of wastewater in Berlin over 17 months shows this technique could help forecast disease outbreaks and monitor the spread of human pathogens. It can also reveal thousands of novel viruses, according to a study by the…
Researchers in Gary Lewin’s lab at the Max Delbrück Center have identified an ion channel that contributes to chronic pain, suggesting a new target for pain medication. The study was published in “Brain.”